156
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Effectiveness and Safety of the PD-1 Inhibitor Lenvatinib Plus Radiotherapy in Patients with HCC with Main PVTT: Real-World Data from a Tertiary Centre

ORCID Icon, , , , , , , & show all
Pages 2037-2048 | Received 22 Aug 2023, Accepted 03 Nov 2023, Published online: 08 Nov 2023